Literature DB >> 40258

Benzodiazepine receptors: cellular and behavioral characteristics.

A S Lippa, D Critchett, M C Sano, C A Klepner, E N Greenblatt, J Coupet, B Beer.   

Abstract

Brain specific benzodiazepine receptors appear to mediate the pharmacological properties of benzodiazepines. A neuronal localization for these receptors is suggested by the parallel decrease in the number of benzodiazepine receptors and cerebellar Purkinje cells in "nervous" mutant mice. Electrophysiological results are compatible with an action of benzodiazepines on neuronally localized, physiological receptors. Biochemical, electrophysiological and behavioral experiments highlight the possible importance of frontal cortex in mediating the anxiolytic properties of the benzodiazepines. Triazolenetetrazoles act upon benzodiazepine receptors, increase punished responding and protect against penetylenetetrazole-induced convulsions, but do not produce the side effects associated with benzodiazepines or affect classical neurotransmitter systems. The structural similarities between triazolopyridazines, purines and the indole portion of certain peptides may provide insights into the nature of the endogenous ligand.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 40258     DOI: 10.1016/0091-3057(79)90342-3

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  17 in total

1.  Daytime wakefulness following a bedtime oral dose of zolpidem 20 mg, flunitrazepam 2 mg and placebo.

Authors:  G Bensimon; J Foret; D Warot; L Lacomblez; J F Thiercelin; P Simon
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

2.  Effects of non-sedative anxiolytic drugs on responses to GABA and on diazepam-induced enhancement of these responses on mouse neurones in cell culture.

Authors:  P P De Deyn; R L Macdonald
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

3.  Effects of benzodiazepines and non-benzodiazepine compounds on the GABA-induced response in frog isolated sensory neurones.

Authors:  T Yakushiji; T Fukuda; Y Oyama; N Akaike
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

4.  Acute noise stress in rats increases the levels of diazepam binding inhibitor (DBI) in hippocampus and adrenal gland.

Authors:  C Ferrarese; T Mennini; N Pecora; M Gobbi; I Appollonio; P Bernasconi; M Frigo; C Regondi; C Pierpaoli; L Frattola
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

5.  Autoradiography of benzodiazepine receptor binding in the central nervous system of the normal C57BL6J mouse.

Authors:  T J Biscoe; J P Fry; C Rickets
Journal:  J Physiol       Date:  1984-07       Impact factor: 5.182

6.  Sleep and benzodiazepine receptor sub-types.

Authors:  W B Mendelson; J V Martin; M Perlis; R Wagner
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

7.  In vivo benzodiazepine receptor occupancy by CL 218,872 visualized by positron emission tomography in the brain of the living baboon: modulation by GABAergic transmission and relation with anticonvulsant activity.

Authors:  V de la Sayette; C Chavoix; E Brouillet; P Hantraye; M Kunimoto; M Khalili-Varasteh; B Guibert; C Prenant; M Mazière
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

8.  Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics.

Authors:  Y Kiuchi; T Kobayashi; J Takeuchi; H Shimizu; H Ogata; M Toru
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

9.  Comparison of the effects of chlordiazepoxide and CL 218,872 on serum corticosterone concentrations in rats.

Authors:  J F McElroy; J M Miller; J S Meyer
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

10.  Interaction between phenytoin and diazepam in mutant Han-Wistar rats with progressive spastic paresis.

Authors:  L Turski; M Schwarz; K H Sontag
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-10       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.